Pasar al contenido principal

ALTERNATIVAS TERAPEUTICAS A LOS BENZIMIDAZOLES PARA LAS ZOONOSIS PARASITARIAS MEDIANTE DISEÑO BASADO EN LA DIANA

RTI2018-099474-B-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE SALAMANCA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Methylsulfanylpyridine based diheteroaryl isocombretastatin analogs as potent anti-proliferative agents

  • Álvarez, Raquel
  • Aramburu, Laura
  • Gajate, Consuelo
  • Vicente-Blázquez, Alba
  • Mollinedo, Faustino
  • Medarde, Manuel
  • Peláez, Rafael
22 p.-7 fig.-2 tab., Isocombretastatins are the not isomerizable 1,1-diarylethene isomers of combretastatins. Both families of antimitotics are poorly soluble and new analogs with improved water solubility are needed. The ubiquitous 3,4,5-trimethoxyphenyl ring and most of its replacements contribute to the solubility problem. 39 new compounds belonging to two series of isocombretastatin analogs with 2-chloro-6-methylsulfanyl-4-pyridinyl or 2,6-bis(methylsulfanyl)-4-pyridinyl moieties replacing the 3,4,5-trimethoxyphenyl have been synthesized and their antimitotic activity and aqueous solubility have been studied. We show here that 2-chloro-6-methylsulfanylpyridines are more successful replacements than 2,6-bis(methylsulfanyl)pyridines, giving highly potent tubulin inhibitors and cytotoxic compounds with improved water solubilities.The optimal combination is with indole rings carrying polar substitutions at the three position.The resulting diheteroaryl isocombretastatin analogs showed potent cytotoxic activity against human cancer cell lines caused by tubulin inhibition, as shown by in vitro tubulin polymerization inhibitory assays, cell cycle analysis, and confocal microscopy studies. Cell cycle analysis also showed apoptotic responses following G2/M arrest after treatment. Conformational analysis and docking studies were applied to propose binding modes of the compounds at the colchicine site of tubulin and were in good agreement with the observed SAR. 2-Chloro-6-methylsulfanylpyridines represent a new and successful trimethoxyphenyl ring substitution for the development of improved colchicine site ligands., This work was supported by the Consejería de Educación de la Junta de Castilla y León (SA030U16 and SA262P18), co-funded by the EU’s European Regional Development Fund-FEDER, and the Spanish Ministry of Science, Innovation, and Universities (RTI2018-099474-B-I00 and SAF2017-89672-R)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

New indolesulfonamide derivatives targeting the colchicine site of tubulin: synthesis, anti-tumour activity, structure–activity relationships, and molecular modelling

  • Vicente-Blázquez, Alba
  • González, Myriam
  • Medarde, Manuel
  • Mollinedo, Faustino
  • Peláez, Rafael
21 p.-4 fig.-3 tab., Searching for improved indolesulfonamides with higher polarities, 45 new analogues with modifications on the sulfonamide nitrogen, the methoxyaniline, and/or the indole 3-position were synthesised. They show submicromolar to nanomolar antiproliferative IC50 values against four human tumour cell lines and they are not P-glycoprotein substrates as their potencies against HeLa cells did not improve upon cotreatment with multidrug resistance (MDR) inhibitors. The compounds inhibit tubulin polymerisation in vitro and in cells, thus causing a mitotic arrest followed by apoptosis as shown by cell cycle distribution studies. Molecular modelling studies indicate binding at the colchicine site. Methylated sulfonamides were more potent than those with large and polar substitutions. Amide, formyl, or nitrile groups at the indole 3-position provided drug-like properties for reduced toxicity, with Polar Surface Areas (PSA) above a desirable 75 Å2. Nitriles 15 and 16 are potent polar analogues and represent an interesting class of new antimitotics., This work was financially supported by the Consejería de Educacion de la Junta de Castilla y León [SA262P18 and SA116P20], co-funded by the EU’s European Regional Development Fund-FEDER, and the Spanish Ministry of Science,Innovation, and Universities [RTI2018-099474-B-I00 and SAF2017-89672-R]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Microtubule Destabilizing Sulfonamides as an Alternative to Taxane-Based Chemotherapy

  • González, Myriam
  • Ovejero-Sánchez, María
  • Vicente-Blázquez, Alba
  • Álvarez, Raquel
  • Herrero, Ana B.
  • Medarde, Manuel
  • González-Sarmiento, Rogelio
  • Peláez, Rafael
© 2021 by the authors., Pan-Gyn cancers entail 1 in 5 cancer cases worldwide, breast cancer being the most commonly diagnosed and responsible for most cancer deaths in women. The high incidence and mortality of these malignancies, together with the handicaps of taxanes—first-line treatments—turn the development of alternative therapeutics into an urgency. Taxanes exhibit low water solubility that require formulations that involve side effects. These drugs are often associated with dose-limiting toxicities and with the appearance of multi-drug resistance (MDR). Here, we propose targeting tubulin with compounds directed to the colchicine site, as their smaller size offer pharmacokinetic advantages and make them less prone to MDR efflux. We have prepared 52 new Microtubule Destabilizing Sulfonamides (MDS) that mostly avoid MDR-mediated resistance and with improved aqueous solubility. The most potent compounds, N-methyl-N-(3,4,5-trimethoxyphenyl-4-methylaminobenzenesulfonamide 38, N-methyl-N-(3,4,5-trimethoxyphenyl-4-methoxy-3-aminobenzenesulfonamide 42, and N-benzyl-N-(3,4,5-trimethoxyphenyl-4-methoxy-3-aminobenzenesulfonamide 45 show nanomolar antiproliferative potencies against ovarian, breast, and cervix carcinoma cells, similar or even better than paclitaxel. Compounds behave as tubulin-binding agents, causing an evident disruption of the microtubule network, in vitro Tubulin Polymerization Inhibition (TPI), and mitotic catastrophe followed by apoptosis. Our results suggest that these novel MDS may be promising alternatives to taxane-based chemotherapy in chemoresistant Pan-Gyn cancers., This research was funded by the Consejería de Educación de la Junta de Castilla y León (SA030U16, SA262P18 and SA116P20), co-funded by the EU’s European Regional Development Fund-FEDER, the Spanish Ministry of Science, Innovation and Universities (RTI2018-099474-BI00) and the health research program of the Instituto de Salud Carlos III (Spanish Ministry of Economy and Competitiveness, PI16/01920 and PI20/01569) co-funded with FEDER founds
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Panobinostat synergistically enhances the cytotoxicity of microtubule destabilizing drugs in ovarian cancer cells

  • Ovejero-Sánchez, María
  • Asensio-Juárez, Gloria
  • González, Myriam
  • Puebla, Pilar
  • Vicente-Manzanares, Miguel
  • Peláez, Rafael
  • González-Sarmiento, Rogelio
  • Herrero, Ana B.
Ovarian cancer (OC) is one of the most common gynecologic neoplasia and has the highest mortality rate, which is mainly due to late-stage diagnosis and chemotherapy resistance. There is an urgent need to explore new and better therapeutic strategies. We have previously described a family of Microtubule Destabilizing Sulfonamides (MDS) that does not trigger multidrug-mediated resistance in OC cell lines. MDS bind to the colchicine site of tubulin, disrupting the microtubule network and causing antiproliferative and cytotoxic effects. In this work, a novel microtubule-destabilizing agent (PILA9) was synthetized and characterized. This compound also inhibited OC cell proliferation and induced G2/M cell cycle arrest and apoptosis. Interestingly, PILA9 was significantly more cytotoxic than MDS. Here, we also analyzed the effect of these microtubule-destabilizing agents (MDA) in combination with Panobinostat, a pan-histone deacetylase inhibitor. We found that Panobinostat synergistically enhanced MDA-cytotoxicity. Mechanistically, we observed that Panobinostat and MDA induced α-tubulin acetylation and that the combination of both agents enhanced this effect, which could be related to the observed synergy. Altogether, our results suggest that MDA/Panobinostat combinations could represent new therapeutic strategies against OC., This study was supported by the health research program of the “Instituto de Salud Carlos III” (Spanish Ministry of Economy and Competitiveness, PI16/01920 and PI20/01569) co-funded with FEDER funds, the Spanish Ministry of Science and Innovation (PID2020-116232RB-I00 and RTI2018-099474-BI00), and projects CSI264P20 and SA116P20 from “Consejería de Educación de la Junta de Castilla y León” co-funded by the EU’s European Regional Development Fund-FEDER, and project AECC/AIRC/CRUK (ECRIN-M3). M.O.-S. was supported by a predoctoral research grant from the Institute of Biomedical Research of Salamanca (IBSAL) (IBpredoc17/00010). G.A.-J. is supported by a Junta de Castilla y León predoctoral fellowship.